MEPSGEN was singled out as a star at the conference!

 MEPSGEN recently participated in the MPS World Summit 2023 in Berlin, Germany as a Silver sponsor. 

The company had a successful showing at the event, meeting with potential customers, partners, 

and investors, and presenting its latest research on the use of MEPS-X series.

Our research showed that MEPS-X products can be used to model a variety of human diseases, including cancer, cardiovascular disease, and neurodegenerative diseases.

MEPSGEN’s platform was in high demand in the market, and we were acknowledged as well-positioned for continued growth in the years to come. 

People were eager to learn more about our products and we tried our best to provide them with clear and concise information at booth #26.

“The MPS World Summit is a great opportunity for us to showcase our technology and meet with other leading companies in the field,” said YongTae Kim, CEO of MEPSGEN. 

“We’re very excited about the future of MPS, and we believe that our platform has the potential to revolutionize the way drugs are discovered and developed,” 

he continued, after giving in-depth information on MEPSGEN’s MEPS-TBC(Tissue-to-Tissue Barrier Chip) and MEPS-VOC(Vascularized Organoids).

During this event, MEPSGEN not had one of the most fantastic booths, but also prepared a poster about 

“Manufactured Microphysiological System for Modeling Tissue-to-Tissue Barriers.” 

It provided the participants with the information they needed to know about the model, 

and it helped to spread the great achievement of the project to a wider audience.

Thanks to everyone who stopped at our booth, for all the fruitful discussions and your great interest in our products! 

We are looking forward to seeing you all again in the nearest future!